Platelets drive macrophage inflammatory activation in vitro
Macrophages have a dual role in tissue healing after injury as they perform tissue repair functions but can also precipitate tissue damage or promote fibrosis. Platelets, beyond their role in thrombosis and hemostasis, are crucial mediators of inflammation and interact with macrophages. Platelet-macrophage interactions have been proposed to modulate macrophage phenotype, including their profibrotic functions, but the full extent of the platelet impact on the macrophage transcriptome is unknown. Here, we aimed to investigate how platelets affect macrophage activation in vitro. Using experimental myocardial infarction (MI) in mice as a model of sterile tissue injury, we readily visualized the direct interaction of platelets with macrophages in the ischemic heart using fluorescence microscopy. Bulk RNA-sequencing of mouse bone marrow-derived macrophages co-cultured in vitro with thrombin-activated platelets showed a widespread proinflammatory activation, with upregulation of genes associated with inflammation (Il1b, Trem1, Tlr2, Cd14), angiogenesis (Vegfa) and response to hypoxia (Hif1a). Resting platelets also led to activation of inflammatory gene expression by macrophages, albeit to a much lesser extent. Activated or resting platelets, or the platelet-derived chemokine CXCL4, had a limited impact on macrophage expression of profibrotic genes (Spp1, Fn1). Using a transwell assay, we further demonstrate that the proinflammatory effects of platelets on the macrophage transcriptome were largely contact dependent. Altogether, our work shows that platelets interact with macrophages in the ischemic heart and polarize macrophages towards a proinflammatory phenotype in vitro, with potential implications for cardiac macrophage inflammatory activation after acute experimental MI.
Authors
- Sarah Beck (ORCID: https://orcid.org/0000-0002-7102-8241)
- Bernhard Nieswandt (ORCID: https://orcid.org/0000-0003-1454-7413)
- Anna Rizakou
- Annabelle Rosa (ORCID: https://orcid.org/0000-0003-2523-5204)
- Harald Schulze (ORCID: https://orcid.org/0000-0003-1285-6407)
- Alma Zernecke (ORCID: https://orcid.org/0000-0001-8551-4729)
- Clément Cochain (ORCID: https://orcid.org/0000-0002-0340-1745)
- Sourish Reddy Bandi (ORCID: https://orcid.org/0000-0002-6672-1391)
- Philipp Burkard (ORCID: https://orcid.org/0000-0001-9748-7967)
- Lukas Johannes Weiss (ORCID: https://orcid.org/0000-0002-7550-2115)
- Marie Piollet (ORCID: https://orcid.org/0000-0002-2025-6594)
- Vanessa Göb (ORCID: https://orcid.org/0000-0003-0813-8680)
- Panagiota Arampatzi (ORCID: https://orcid.org/0000-0001-7925-8984)
- Ecem T. Sakalli (ORCID: https://orcid.org/0000-0001-5121-9369)
- David Stegner (ORCID: https://orcid.org/0000-0003-1059-9865)
- Giuseppe Rizzo (ORCID: https://orcid.org/0009-0008-5366-0738)
- Kimberly Klapproth
- Shanice Gundel
Institutions
- Inserm (FR)
- Université Paris Cité (FR)
- University of Würzburg (DE)
- Universitätsklinikum Würzburg (DE)
- Paris Cardiovascular Research Center (FR)
Publication Details
- Journal
- Journal of Leukocyte Biology
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1093/jleuko/qiaf114
- Citations
- 2
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.54
Funders
- Deutsche Forschungsgemeinschaft
- Julius-Maximilians-Universität Würzburg